Skip to content Home / Companies / VERA VER
Vera Therapeutics, Inc. (VERA) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest VERA Insider Trades
About Vera Therapeutics, Inc. (VERA) Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Headquarters BRISBANE, CA
Employees 361
Listed 2021
Exchange XNAS https://www.veratx.com SEC filings for VERA on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 8 83,250 $3.36M Grant or award 2 107,998 Option exercise 2 37,000
VERA Insider Transactions (Form 4) 49 49 Form 4 filings on record, the earliest from Oct 11, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Jun 23, 2026 MF Marshall Fordyce - Officer Option exercise Class A Common Stock 18,500
Recent VERA Form 8-K Filings 5
Recent VERA Form 144 Notices of Proposed Sale 2 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Jun 23, 2026 - - - - View on EDGAR May 12, 2026 - - -
VERA Insider Trading - FAQ
What is the latest insider trade for VERA? Vera Therapeutics, Inc. (VERA) had 4 insider filings in the last 90 days, with the most recent on 2026-08-12. The full record for VERA runs to 49 Form 4 filings, the earliest from 2024-10-11. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying VERA stock? No insider purchases of VERA were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling VERA stock? 8 insider sales of VERA were filed in the last 90 days, totaling $3.36M.
Where can I see VERA SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks VERA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow VERA insider buys? Create a free InsiderAlpha account and press Watch on this page to add VERA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track VERA insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free Jun 23, 2026
Market cap $2.46B
P/E ratio -
Dividend yield -
Average volume 2.04M
52 week high $56.05
52 week low $21.20
Today's high $34.22
Today's low $33.18
Open $33.64
Volume 557.5K
Previous close $34.19
Shares outstanding 72.06M Market cap
$2.46B
361 employees
VERA Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 8 sales totaling $3.36M.
Most-Active VERA Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Jun 23, 2026 MF Marshall Fordyce - Officer Open-market sale Class A Common Stock 18,412 $37.93 $698K
Jun 23, 2026 MF Marshall Fordyce - Officer Open-market sale Class A Common Stock 88 $38.43 $3K
Jun 23, 2026 MF Marshall Fordyce - Officer Option exercise Stock Option (Right to Buy) 18,500 $0.00 -
Aug 3, 2026 NB Nancy Lee Boman - Officer Grant or award Class A Common Stock 44,987 $0.00 -
Aug 3, 2026 NB Nancy Lee Boman - Officer Grant or award Stock Option (right to buy) 63,011 $0.00 -
Jul 7, 2026 MF Marshall Fordyce - Officer Open-market sale Class A Common Stock 1,000 $40.78 $41K
Jul 7, 2026 MF Marshall Fordyce - Officer Open-market sale Class A Common Stock 32,550 $42.07 $1.37M
Jul 7, 2026 MF Marshall Fordyce - Officer Open-market sale Class A Common Stock 10,500 $42.86 $450K
Jul 7, 2026 MF Marshall Fordyce - Officer Open-market sale Class A Common Stock 2,200 $43.59 $96K
Jun 23, 2026 MF Marshall Fordyce - Officer Open-market sale Class A Common Stock 18,412 $37.93 $698K
Jun 23, 2026 MF Marshall Fordyce - Officer Open-market sale Class A Common Stock 88 $38.43 $3K
May 21, 2026 AC Andrew Cheng Grant or award Stock Option (right to buy) 17,084 $0.00 -
May 21, 2026 JM James R. Meyers Grant or award Stock Option (right to buy) 17,084 $0.00 -
May 21, 2026 KH Kimball Hall Grant or award Stock Option (right to buy) 17,084 $0.00 -
May 12, 2026 MF Marshall Fordyce - Officer Open-market sale Class A Common Stock 14,219 $36.64 $521K
May 12, 2026 MF Marshall Fordyce - Officer Open-market sale Class A Common Stock 4,281 $37.09 $159K
Apr 14, 2026 MF Marshall Fordyce - Officer Open-market sale Class A Common Stock 14,130 $43.66 $617K
Apr 14, 2026 MF Marshall Fordyce - Officer Open-market sale Class A Common Stock 7,921 $44.58 $353K
Apr 14, 2026 MF Marshall Fordyce - Officer Open-market sale Class A Common Stock 900 $45.51 $41K
Mar 13, 2026 JY Joseph R. Young - Officer Option exercise Class A Common Stock 10,000 $3.94 $39K
Mar 13, 2026 JY Joseph R. Young - Officer Option exercise Stock Option (right to buy) 10,000 $0.00 -
Mar 5, 2026 CH Christopher Hite Grant or award Stock Option (right to buy) 24,937 $0.00 -
Feb 23, 2026 RB Robert Brenner - Officer Open-market sale Class A Common Stock 2,151 $41.98 $90K
Feb 23, 2026 JY Joseph R. Young - Officer Open-market sale Class A Common Stock 3,117 $41.98 $131K
Feb 23, 2026 SG Sean Grant - Officer Open-market sale Class A Common Stock 4,949 $41.98 $208K
Feb 23, 2026 MF Marshall Fordyce - Officer Open-market sale Class A Common Stock 16,925 $41.98 $711K
Feb 23, 2026 DJ David Lee Johnson - Officer Open-market sale Class A Common Stock 2,579 $41.98 $108K
Feb 23, 2026 WT William D. Turner - Officer Open-market sale Class A Common Stock 2,187 $41.98 $92K
Feb 4, 2026 JY Joseph R. Young - Officer Grant or award Class A Common Stock 10,000 $0.00 -
Feb 4, 2026 JY Joseph R. Young - Officer Grant or award Stock Option (right to buy) 20,000 $0.00 -
Feb 4, 2026 MF Marshall Fordyce - Officer Grant or award Class A Common Stock 68,800 $0.00 -
Feb 4, 2026 MF Marshall Fordyce - Officer Grant or award Stock Option (right to buy) 137,500 $0.00 -
Feb 4, 2026 SG Sean Grant - Officer Grant or award Class A Common Stock 25,000 $0.00 -
Feb 4, 2026 SG Sean Grant - Officer Grant or award Stock Option (right to buy) 50,000 $0.00 -
Feb 4, 2026 WT William D. Turner - Officer Grant or award Class A Common Stock 25,000 $0.00 -
Feb 4, 2026 WT William D. Turner - Officer Grant or award Stock Option (right to buy) 50,000 $0.00 -
Feb 4, 2026 DJ David Lee Johnson - Officer Grant or award Class A Common Stock 20,000 $0.00 -
Feb 4, 2026 DJ David Lee Johnson - Officer Grant or award Stock Option (right to buy) 40,000 $0.00 -
$VKTX
Viking Therapeutics, Inc.
$IONS
IONIS PHARMACEUTICALS INC
